132 related articles for article (PubMed ID: 20712564)
1. Medicinal chemistry of 2,2,4-substituted morpholines.
Rekka EA; Kourounakis PN
Curr Med Chem; 2010; 17(29):3422-30. PubMed ID: 20712564
[TBL] [Abstract][Full Text] [Related]
2. Nitric oxide releasing morpholine derivatives as hypolipidemic and antioxidant agents.
Chrysselis MC; Rekka EA; Siskou IC; Kourounakis PN
J Med Chem; 2002 Nov; 45(24):5406-9. PubMed ID: 12431068
[TBL] [Abstract][Full Text] [Related]
3. Thiomorpholine Derivatives with Hypolipidemic and Antioxidant Activity.
Tooulia KK; Theodosis-Nobelos P; Rekka EA
Arch Pharm (Weinheim); 2015 Sep; 348(9):629-34. PubMed ID: 26191791
[TBL] [Abstract][Full Text] [Related]
4. Lipid-lowering (hetero)aromatic tetrahydro-1,4-oxazine derivatives with antioxidant and squalene synthase inhibitory activity.
Kourounakis AP; Charitos C; Rekka EA; Kourounakis PN
J Med Chem; 2008 Sep; 51(18):5861-5. PubMed ID: 18754614
[TBL] [Abstract][Full Text] [Related]
5. Hypocholesterolemic and hypolipidemic activity of some novel morpholine derivatives with antioxidant activity.
Chrysselis MC; Rekka EA; Kourounakis PN
J Med Chem; 2000 Feb; 43(4):609-12. PubMed ID: 10691687
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and effect on free radical processes on some substituted morpholine derivatives with potential biologic activity.
Tani E; Rekka E; Kourounakis PN
Arzneimittelforschung; 1994 Sep; 44(9):992-4. PubMed ID: 7986253
[TBL] [Abstract][Full Text] [Related]
7. Design of more potent squalene synthase inhibitors with multiple activities.
Kourounakis AP; Matralis AN; Nikitakis A
Bioorg Med Chem; 2010 Nov; 18(21):7402-12. PubMed ID: 20888243
[TBL] [Abstract][Full Text] [Related]
8. Amides of non-steroidal anti-inflammatory drugs with thiomorpholine can yield hypolipidemic agents with improved anti-inflammatory activity.
Theodosis-Nobelos P; Kourti M; Gavalas A; Rekka EA
Bioorg Med Chem Lett; 2016 Feb; 26(3):910-913. PubMed ID: 26750253
[TBL] [Abstract][Full Text] [Related]
9. Effect of some biologically interesting substituted tetrahydro-1,4-oxazines on drug metabolising enzymes and on inflammation.
Rekka EA; Kourounakis AP; Avramidis N; Kourounakis PN
Curr Drug Metab; 2005 Oct; 6(5):481-5. PubMed ID: 16248839
[TBL] [Abstract][Full Text] [Related]
10. Developing potential agents against atherosclerosis: Design, synthesis and pharmacological evaluation of novel dual inhibitors of oxidative stress and Squalene Synthase activity.
Katselou MG; Matralis AN; Kourounakis AP
Eur J Med Chem; 2017 Sep; 138():748-760. PubMed ID: 28728107
[TBL] [Abstract][Full Text] [Related]
11. Balancing Antioxidant, Hypolipidemic and Anti-inflammatory Activity in a Single Agent: The Example of 2-Hydroxy-2-Substituted Morpholine, 1,4-Benzoxazine and 1,4-Benzothiazine Derivatives as a Rational Therapeutic Approach against Atherosclerosis.
Matralis AN; Bavavea EI; Incerpi S; Pedersen JZ; Kourounakis AP
Curr Med Chem; 2017; 24(12):1214-1227. PubMed ID: 27528055
[TBL] [Abstract][Full Text] [Related]
12. Antihyperlipidemic morpholine derivatives with antioxidant activity: An investigation of the aromatic substitution.
Ladopoulou EM; Matralis AN; Nikitakis A; Kourounakis AP
Bioorg Med Chem; 2015 Nov; 23(21):7015-23. PubMed ID: 26433631
[TBL] [Abstract][Full Text] [Related]
13. Novel keto-enamine Schiffs bases from 7-hydroxy-4-methyl-2-oxo-2H-benzo[h] chromene-8,10-dicarbaldehyde as potential antidyslipidemic and antioxidant agents.
Sashidhara KV; Rosaiah JN; Bhatia G; Saxena JK
Eur J Med Chem; 2008 Nov; 43(11):2592-6. PubMed ID: 18063225
[TBL] [Abstract][Full Text] [Related]
14. Antioxidant Serine-(NSAID) Hybrids with Anti-Inflammatory and Hypolipidemic Potency.
Theodosis-Nobelos P; Papagiouvannis G; Tziona P; Kourounakis PN; Rekka EA
Molecules; 2021 Jul; 26(13):. PubMed ID: 34279399
[TBL] [Abstract][Full Text] [Related]
15. Development of Fibrates as Important Scaffolds in Medicinal Chemistry.
Giampietro L; Ammazzalorso A; Amoroso R; De Filippis B
ChemMedChem; 2019 Jun; 14(11):1051-1066. PubMed ID: 30957432
[TBL] [Abstract][Full Text] [Related]
16. Novel 2-(nitrooxy)ethyl 2-(4-(substituted phenyl)-2-((substituted phenyl)amino)thiazol-5-yl)acetate as Anti-inflammatory, Analgesic and Nitric Oxide Releasing Agents: Synthesis and Molecular Docking Studies.
Sarkate AP; Lokwani DK; Karnik KS; Shinde DB
Antiinflamm Antiallergy Agents Med Chem; 2017; 16(3):153-167. PubMed ID: 29141568
[TBL] [Abstract][Full Text] [Related]
17. Lipophilicity of some substituted morpholine derivatives synthesized as potential antinociceptive agents.
Rekka E; Retsas S; Demopoulos VJ; Kourounakis PN
Arch Pharm (Weinheim); 1990 Jan; 323(1):53-6. PubMed ID: 2334269
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and hypolipidemic activity of novel 2-(4-(2-amino-6-(4-substituted phenyl) pyrimidin-4-yl)-2-substituted phenoxy) acetic acid derivatives.
Mokale SN; Shete MT; Shaikh SI; Shinde DB
Chem Biol Drug Des; 2012 Apr; 79(4):548-52. PubMed ID: 22226122
[TBL] [Abstract][Full Text] [Related]
19. Synthesis, structure elucidation, DNA-PK, PI3K, anti-platelet and anti-bacteria activity of linear 5, 6, and 10-substituted-2-morpholino-chromen-oxazine-dione and angular 3, 4, 6-substituted-8-morpholino-chromen-oxazine-2,10-dione.
Morrison R; Al-Rawi JM
J Enzyme Inhib Med Chem; 2016; 31(sup2):86-95. PubMed ID: 27255290
[TBL] [Abstract][Full Text] [Related]
20. New multifunctional Di-tert-butylphenoloctahydro(pyrido/benz)oxazine derivatives with antioxidant, antihyperlipidemic, and antidiabetic action.
Ladopoulou E; Matralis AN; Kourounakis AP
J Med Chem; 2013 Apr; 56(8):3330-8. PubMed ID: 23581491
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
